Residual disease activity in patient reaching low disease activity or MDA
| DAPSA LDA (195) | cDAPSA LDA (195) | MDA5/7 (162) | MDA joints (117) | MDA skin (120) | MDA skin and joints (83) | PASDAS LDA (151) | |
| Swollen joint count, N (%) | |||||||
| 0 | 143 (74) | 143 (73) | 126 (78) | 101 (86) | 92 (77) | 78 (94) | 115 (75) |
| 1–3 | 48 (25) | 48 (25) | 33 (20) | 16 (14) | 26 (22) | 5 (6) | 32 (21) |
| 4–6 | 4 (2) | 4 (2) | 3 (2) | 0 (0) | 2 (2) | 0 (0) | 6 (4) |
| Tender joint count, N (%) | |||||||
| 0 | 110 (56) | 111 (56) | 103 (64) | 106 (91) | 76 (63) | 75 (90) | 90 (59) |
| 1–3 | 56 (29) | 56 (29) | 39 (24) | 11 (9) | 28 (23) | 8 (10) | 36 (24) |
| 4–7 | 19 (10) | 19 (10) | 12 (7) | 0 (0) | 12 (10) | 0 (0) | 15 (10) |
| 8+ | 6 (3) | 5 (3) | 6 (4) | 0 (0) | 4 (3) | 0 (0) | 10 (7) |
| Enthesitis count, N (%) | |||||||
| 0 | 186 (95) | 187 (96) | 157 (97) | 112 (96) | 116 (97) | 79 (95) | 148 (98) |
| 1–2 | 7 (4) | 6 (3) | 4 (2) | 4 (3) | 3 (2) | 3 (4) | 0 (0) |
| 3–4 | 2 (1) | 2 (1) | 1 (1) | 1 (1) | 1 (1) | 1 (1) | 3 (2) |
| Dactylitis count | |||||||
| 0 | 195 (100) | 195 (100) | 162 (100) | 117 (100) | 120 (100) | 83 (100) | 151 (100) |
| PASI, N (%) | |||||||
| 0–1 | 136 (70) | 136 (70) | 120 (74) | 83 (71) | 120 (100) | 83 (100) | 108 (54) |
| >1 | 59 (30) | 59 (30) | 42 (26) | 34 (29) | 0 (0) | 0 (0) | 43 (46) |
| CRP (Normal<5 mg/dL), N (%) | |||||||
| Raised | 22 (11) | 22 (11) | 18 (11) | 12 (10) | 15 (13) | 10 (12) | 16 (11) |